Diagnostic value of the PPI test for detection of GERD in Korean patients and factors associated with PPI responsiveness

References

• Tytgat GN, McColl K, Tack J, Holtmann G, Hunt RH, Malfertheiner P, New algorithm for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2008;27:249–56.
   PubMed Web of Science ®Google Scholar
• Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004;140:518–27.
   PubMed Web of Science ®Google Scholar
• Gasiorowska A, Fass R. The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol 2008;42:867–74.
   PubMed Web of Science ®Google Scholar
• Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008;23:8–22.
   PubMed Web of Science ®Google Scholar
• Xia HH, Lai KC, Lam SK, Hu WH, Wong NY, Hui WM, Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment Pharmacol Ther 2003;17:369–77.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Kwon HC, Cheong JY, Cho SW. Demographic, Clinical, and Psychological Characteristics of the Heartburn Groups Classified Using the Rome III Criteria and Factors Associated with the Responsiveness to Proton Pump Inhibitors in the Gastroesophageal Reflux Disease Group. Digestion 2009;79:131–6.
   PubMed Web of Science ®Google Scholar
• Wu JC, Chan FK, Ching JY, Leung WK, Lee YT, Sung JJ. Empirical treatment based on ‘typical’ reflux symptoms is appropriate in a population with a high prevalence of Helicobacter pylori infection. Gastrointest Endosc 2002;55:461–5.
   PubMed Web of Science ®Google Scholar
• Lee ES, Kim N, Lee SH, Park YS, Kim JW, Jeong SH, Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive esophagitis and non-erosive reflux disease. Aliment Pharmacol Ther 2009;30:154–64.
   PubMed Web of Science ®Google Scholar
• Sinn DH, Kim JH, Kim S, Son HJ, Kim JJ, Rhee JC, Rhee PL. Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus. Aliment Pharmacol Ther 2008;27:1275–81.
   PubMed Web of Science ®Google Scholar
• Wenner J, Johnsson F, Johansson J, Oberg1 S. Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol 2005;40:768–74.
   PubMed Web of Science ®Google Scholar
• Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994;107:1741–5.
   PubMed Web of Science ®Google Scholar
• Sewitch MJ, Abrahamowicz M, Bitton A, Daly D, Wild GE, Cohen A, Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:1470–9.
   PubMed Web of Science ®Google Scholar
• Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Non-erosive reflux disease – defining the entity and delineating the management. Digestion 2008;78(Suppl 1):1–5.
   PubMedGoogle Scholar
• Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004;2:656–64.
   PubMed Web of Science ®Google Scholar
• Ahlawat SK, Novak DJ, Williams DC, Maher KA, Barton F, Benjamin SB. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system. J Clin Gastroenterol 2006;40:20–4.
   PubMed Web of Science ®Google Scholar
• Watson RG, Tham TC, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux – the “sensitive oesophagus”. Gut 1997;40:587–90.
   PubMed Web of Science ®Google Scholar
• Aanen MC, Weusten BL, Numans ME, de Wit NJ, Baron A, Smout AJ. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2006;24:1377–84.
   PubMed Web of Science ®Google Scholar
• Taghavi SA, Ghasedi M, Saberi-Firoozi M, Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 2005;54:1067–71.
   PubMed Web of Science ®Google Scholar
• Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 1993;88:11–19.
   PubMed Web of Science ®Google Scholar